Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Gut. 2021 Dec;70(12):2321-2329. doi: 10.1136/gutjnl-2020-322545. Epub 2021 Jan 25.
To measure the effects of faecal immunochemical test (FIT) for colorectal cancer (CRC) screening on overall and site-specific long-term effectiveness of population-based organised service screening.
A prospective cohort study of Taiwanese nationwide biennial FIT screening was performed. A total of 5 417 699 eligible subjects were invited to attend screening from 2004 through 2009 and were followed up until 2014. We estimated the adjusted relative rates (aRRs) on the effectiveness of reducing advanced-stage CRC (stage II+) and CRC death by Bayesian Poisson regression models with the full adjustment for a cascade of self-selection factors (including the screening rate and the colonoscopy rate) and the completeness of colonoscopy together with demographic features.
FIT screening (exposed vs unexposed) reduced the incidence of advanced-stage CRC (48.4 vs 75.7 per 100 000) and mortality (20.3 vs 41.3 per 100 000). Statistically significant reductions of both incidence of advanced-stage CRCs (aRR=0.66, 95% CI 0.63 to 0.70) and deaths from CRC (aRR=0.60, 95% CI 0.57 to 0.64) were noted. FIT screening was more effective in reducing distal advanced-stage CRCs (aRR=0.61, 95% CI 0.58 to 0.64) and CRC mortality (aRR=0.56, 95% CI 0.53 to 0.69) than proximal advanced CRCs (aRR=0.84, 95% CI 0.77 to 0.92) and CRC mortality (aRR=0.72, 95% CI 0.66 to 0.80).
A large-scale population-based biennial FIT screening demonstrates 34% significant reduction of advanced-stage CRCs and 40% reduction of death from CRC with larger long-term effectiveness in the distal colon than the proximal colon. Our findings provide a strong and consistent evidence-based policy for supporting a sustainable population-based FIT organised service screening worldwide. The disparity of site-specific long-term effectiveness also provides an insight into the remedy for lower effectiveness of FIT screening in the proximal colon.
测量粪便免疫化学试验(FIT)在基于人群的有组织服务筛查中的结直肠癌(CRC)筛查对总体和特定部位长期有效性的影响。
对台湾全国性的两年一次的 FIT 筛查进行了前瞻性队列研究。2004 年至 2009 年,共有 5417699 名符合条件的受试者被邀请参加筛查,并随访至 2014 年。我们通过贝叶斯泊松回归模型估计了通过全调整级联的自我选择因素(包括筛查率和结肠镜检查率)和结肠镜检查的完整性以及人口统计学特征来降低晚期 CRC(II+期)和 CRC 死亡的调整相对率(aRR)。
FIT 筛查(暴露与未暴露)降低了晚期 CRC(每 100000 人 48.4 例 vs 75.7 例)和死亡率(每 100000 人 20.3 例 vs 41.3 例)的发生率。观察到晚期 CRC 发生率(aRR=0.66,95%CI0.63 至 0.70)和 CRC 死亡率(aRR=0.60,95%CI0.57 至 0.64)均有统计学显著降低。FIT 筛查在降低远端晚期 CRC(aRR=0.61,95%CI0.58 至 0.64)和 CRC 死亡率(aRR=0.56,95%CI0.53 至 0.69)方面比近端晚期 CRC(aRR=0.84,95%CI0.77 至 0.92)和 CRC 死亡率(aRR=0.72,95%CI0.66 至 0.80)更有效。
大规模的基于人群的两年一次的 FIT 筛查显示,晚期 CRC 降低了 34%,CRC 死亡率降低了 40%,远端结肠的长期效果优于近端结肠。我们的研究结果为支持全球可持续基于人群的 FIT 有组织服务筛查提供了强有力的、基于证据的政策。特定部位长期有效性的差异也为 FIT 筛查在近端结肠的较低有效性提供了深入了解。